Carverag 25 Tablet

Tablet
Rs.106for 1 strip(s) (10 tablets each)
1
Unfortunately, we don't have any more items in stock
Report Error

Composition FOR Carverag 25mg Tablet

Carvedilol(25mg)

food interaction for Carverag Tablet

alcohol interaction for Carverag Tablet

pregnancy interaction for Carverag Tablet

lactation interaction for Carverag Tablet

food
alcohol
pregnancy
lactation
Carverag 25 Tablet is to be taken with food.
None
CAUTION
It is unsafe to consume alcohol with Carverag 25 Tablet.
UNSAFE
Carverag 25 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
CONSULT YOUR DOCTOR
Carverag 25 Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
SAFE IF PRESCRIBED

SALT INFORMATION FOR Carverag 25mg Tablet

Carvedilol(25mg)

Carverag tablet uses

How carverag tablet works

Carverag 25 Tablet is an alpha and beta blocker. It works by slowing down the heart rate and relaxing blood vessels which makes the heart more efficient at pumping blood around the body.

Common side effects of carverag tablet

Decreased blood pressure, Headache, Fatigue, Dizziness, Breathlessness

SUBSTITUTES FOR Carverag Tablet

17 Substitutes
17 Substitutes
Sorted By
RelevancePrice

Expert advice FOR Carverag Tablet

  • It should be taken with food.
  • Check your blood pressure 1 week after starting Carvedilol, and inform your doctor if it has not improved.
  • Carvedilol may cause dizziness or sleepiness. Do not drive or do anything requiring concentration until you know how it affects you.
  • It is best to avoid drinking alcohol while taking Carvedilol as it may make the side effects worse.
  • Do not stop taking Carvedilol suddenly as it can cause your blood pressure to rise suddenly, thereby increasing the risk of heart attack and stroke.

Frequently asked questions FOR Carverag 25mg Tablet

Carvedilol

Q. What happens when you stop taking Carverag 25 Tablet?
Carverag 25 Tablet needs to be taken regularly as directed by your doctor. Suddenly stopping it may cause chest pain or heart attack. Your doctor may slowly lower your dose over a period of time before stopping it completely if required.
Q. Does Carverag 25 Tablet make you tired?
Yes, Carverag 25 Tablet may make you tired as well as dizzy. These may occur initially when you start the treatment or when the dose is increased. If you experience these symptoms you should not drive or operate machinery.
Q. Can Carverag 25 Tablet cause weight gain?
Yes, weight gain is a common side effect of Carverag 25 Tablet, but it does not occur in everyone. If you are taking Carverag 25 Tablet for heart failure, tell your doctor if you gain weight or have trouble breathing, as this may be a sign of fluid retention.
Show More
Q. Can Carverag 25 Tablet cause kidney failure?
Use of Carverag 25 Tablet in patients with heart failure can rarely lead to deterioration of kidney function. However, Carverag 25 Tablet may cause risk of kidney failure in patients with low blood pressure (systolic blood pressure less than 100 mm Hg), patients with hardening of the arteries and/or having heart disease, or already have impaired kidney function. Such patients should be closely monitored during treatment with Carverag 25 Tablet. Although, kidney functions return to baseline when Carverag 25 Tablet is stopped.
Q. Can a diabetic patient take Carverag 25 Tablet?
Yes, a diabetic patient can take Carverag 25 Tablet, provided that there is a regular check on blood glucose levels. It has been noted that in well-controlled diabetes mellitus with mild to moderate hypertension, Carverag 25 Tablet did not have any effect on blood glucose levels. However, it is important to know that, using Carverag 25 Tablet class of medicines (beta-blockers) may hide the symptoms of hypoglycemia (decrease in glucose levels), especially an increase in heartbeat or palpitations. In addition to that, Carverag 25 Tablet may cause worsening of hyperglycemia (increase in blood glucose levels) in patients with heart failure and diabetes. Hence, it is recommended that blood glucose should be monitored while initiating, adjusting, or discontinuing the dose of Carverag 25 Tablet. Inform the doctor if there is any change in blood glucose levels during Carverag 25 Tablet therapy.
Q. Can I take Carverag 25 Tablet empty stomach?
It is recommended that you take Carverag 25 Tablet with food, as food decreases the rate at which the medicine gets absorbed by the body. This will help to reduce the chances of orthostatic hypotension (low blood pressure which may cause dizziness or fainting when you stand up).
Q. What are the serious side effects of Carverag 25 Tablet?
Carverag 25 Tablet may cause serious side effects such as fainting, shortness of breath, weight gain, swelling of the arms, hands, feet, ankles, or lower legs. Some may also experience chest pain, slow or irregular heartbeat, rash, hives, itching, and difficulty in breathing and swallowing. If you experience any of these symptoms call your doctor immediately.
Q. What if I take more than the recommended dose of Carverag 25 Tablet?
If you take more than the recommended dose of Carverag 25 Tablet you may experience slow heartbeat, dizziness, fainting, difficulty breathing, vomiting, and loss of consciousness or seizures. Contact your doctor and seek immediate medical help in a nearby hospital.
Q. Who should not take Carverag 25 Tablet?
Carverag 25 Tablet should be avoided if the patient has severe heart failure and is hospitalized in the intensive care unit or require certain intravenous medications that help support circulation (inotropic medications). In addition to that, Carverag 25 Tablet should be avoided in patients who are prone to asthma or other breathing problems, have a slow heartbeat or irregular heartbeat, have liver problems, and are allergic to Carverag 25 Tablet.

Content on this page was last updated on 13 December, 2024, by Dr. Varun Gupta (MD Pharmacology)